BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

460 related articles for article (PubMed ID: 32976685)

  • 1. Asperolide A prevents bone metastatic breast cancer via the PI3K/AKT/mTOR/c-Fos/NFATc1 signaling pathway.
    Jiang W; Rixiati Y; Huang H; Shi Y; Huang C; Jiao B
    Cancer Med; 2020 Nov; 9(21):8173-8185. PubMed ID: 32976685
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Morusin inhibits breast cancer-induced osteolysis by decreasing phosphatidylinositol 3-kinase (PI3K)-mTOR signalling.
    Zhang L; Li W; Chen X; Cao D; You S; Shi F; Luo Z; Li H; Zeng X; Song Y; Li N; Akimoto Y; Rui G; Chen Y; Wu Z; Xu R
    Chem Biol Interact; 2024 May; 394():110968. PubMed ID: 38522564
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Purslane suppresses osteoclast differentiation and bone resorbing activity via inhibition of Akt/GSK3β-c-Fos-NFATc1 signaling in vitro and prevents lipopolysaccharide-induced bone loss in vivo.
    Kim JY; Oh HM; Kwak SC; Cheon YH; Lee MS; Rho MC; Oh J
    Biol Pharm Bull; 2015; 38(1):66-74. PubMed ID: 25744460
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Artemisinin inhibits breast cancer-induced osteolysis by inhibiting osteoclast formation and breast cancer cell proliferation.
    Li J; Feng W; Lu H; Wei Y; Ma S; Wei L; Liu Q; Zhao J; Wei Q; Yao J
    J Cell Physiol; 2019 Aug; 234(8):12663-12675. PubMed ID: 30536376
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phosphatidyl inositol 3-kinase (PI3K)-mTOR inhibitor PKI-402 inhibits breast cancer induced osteolysis.
    Yuan G; Lian Z; Liu Q; Lin X; Xie D; Song F; Wang X; Shao S; Zhou B; Li C; Li M; Yao G
    Cancer Lett; 2019 Feb; 443():135-144. PubMed ID: 30540926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caffeic acid 3,4-dihydroxy-phenethyl ester suppresses receptor activator of NF-κB ligand–induced osteoclastogenesis and prevents ovariectomy-induced bone loss through inhibition of mitogen-activated protein kinase/activator protein 1 and Ca2+–nuclear factor of activated T-cells cytoplasmic 1 signaling pathways.
    Wu X; Li Z; Yang Z; Zheng C; Jing J; Chen Y; Ye X; Lian X; Qiu W; Yang F; Tang J; Xiao J; Liu M; Luo J
    J Bone Miner Res; 2012 Jun; 27(6):1298-1308. PubMed ID: 22337253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dihydroartemisinin prevents breast cancer-induced osteolysis via inhibiting both breast caner cells and osteoclasts.
    Feng MX; Hong JX; Wang Q; Fan YY; Yuan CT; Lei XH; Zhu M; Qin A; Chen HX; Hong D
    Sci Rep; 2016 Jan; 6():19074. PubMed ID: 26743690
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diosmetin inhibits osteoclast formation and differentiation and prevents LPS-induced osteolysis in mice.
    Shao S; Fu F; Wang Z; Song F; Li C; Wu ZX; Ding J; Li K; Xiao Y; Su Y; Lin X; Yuan G; Zhao J; Liu Q; Xu J
    J Cell Physiol; 2019 Aug; 234(8):12701-12713. PubMed ID: 30515812
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gold clusters prevent breast cancer bone metastasis by suppressing tumor-induced osteoclastogenesis.
    Zhang Z; Yao Y; Yuan Q; Lu C; Zhang X; Yuan J; Hou K; Zhang C; Du Z; Gao X; Chen X
    Theranostics; 2020; 10(9):4042-4055. PubMed ID: 32226538
    [No Abstract]   [Full Text] [Related]  

  • 10. Abietic acid attenuates RANKL induced osteoclastogenesis and inflammation associated osteolysis by inhibiting the NF-KB and MAPK signaling.
    Thummuri D; Guntuku L; Challa VS; Ramavat RN; Naidu VGM
    J Cell Physiol; 2018 Jan; 234(1):443-453. PubMed ID: 29932225
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Triptolide prevents bone loss via suppressing osteoclastogenesis through inhibiting PI3K-AKT-NFATc1 pathway.
    Cui J; Li X; Wang S; Su Y; Chen X; Cao L; Zhi X; Qiu Z; Wang Y; Jiang H; Huang B; Ji F; Su J
    J Cell Mol Med; 2020 Jun; 24(11):6149-6161. PubMed ID: 32347017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Idelalisib inhibits osteoclast differentiation and pre-osteoclast migration by blocking the PI3Kδ-Akt-c-Fos/NFATc1 signaling cascade.
    Yeon JT; Kim KJ; Son YJ; Park SJ; Kim SH
    Arch Pharm Res; 2019 Aug; 42(8):712-721. PubMed ID: 31161369
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Anti-breast cancer and toxicity studies of total secondary saponin from Anemone raddeana Rhizome on MCF-7 cells via ROS generation and PI3K/AKT/mTOR inactivation.
    Zhang D; Zhang Q; Zheng Y; Lu J
    J Ethnopharmacol; 2020 Sep; 259():112984. PubMed ID: 32446927
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plumbagin inhibits breast tumor bone metastasis and osteolysis by modulating the tumor-bone microenvironment.
    Li Z; Xiao J; Wu X; Li W; Yang Z; Xie J; Xu L; Cai X; Lin Z; Guo W; Luo J; Liu M
    Curr Mol Med; 2012 Sep; 12(8):967-81. PubMed ID: 22574935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sinomenine inhibits osteolysis in breast cancer by reducing IL-8/CXCR1 and c-Fos/NFATc1 signaling.
    Zhang Y; Zou B; Tan Y; Su J; Wang Y; Xu J; Tao L; Zhou H; Liu L; Li X
    Pharmacol Res; 2019 Apr; 142():140-150. PubMed ID: 30797069
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Monocrotaline Suppresses RANKL-Induced Osteoclastogenesis In Vitro and Prevents LPS-Induced Bone Loss In Vivo.
    Wei CM; Su YJ; Qin X; Ding JX; Liu Q; Song FM; Zong SH; Xu J; Zhou B; Zhao JM
    Cell Physiol Biochem; 2018; 48(2):644-656. PubMed ID: 30025412
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Pyrroloquinoline quinine inhibits RANKL-mediated expression of NFATc1 in part via suppression of c-Fos in mouse bone marrow cells and inhibits wear particle-induced osteolysis in mice.
    Kong L; Yang C; Yu L; Smith W; Zhu S; Zhu J; Zhu Q
    PLoS One; 2013; 8(4):e61013. PubMed ID: 23613773
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kalkitoxin Reduces Osteoclast Formation and Resorption and Protects against Inflammatory Bone Loss.
    Li L; Yang M; Shrestha SK; Kim H; Gerwick WH; Soh Y
    Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33669069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trimethylamine-N-Oxide Promotes Osteoclast Differentiation and Bone Loss via Activating ROS-Dependent NF-κB Signaling Pathway.
    Wang N; Hao Y; Fu L
    Nutrients; 2022 Sep; 14(19):. PubMed ID: 36235607
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel 4-aminoquinazoline derivative, DHW-208, suppresses the growth of human breast cancer cells by targeting the PI3K/AKT/mTOR pathway.
    Wang S; Zhang Y; Ren T; Wu Q; Lu H; Qin X; Liu Y; Ding H; Zhao Q
    Cell Death Dis; 2020 Jun; 11(6):491. PubMed ID: 32606352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.